Wordt geladen...
An Update on Pharmacotherapy for Leishmaniasis
INTRODUCTION: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL). The treatment of leishmaniasis is challenging and the armamentarium of drugs is small, duration of treatment is long, and most drugs are toxic. AREAS COVE...
Bewaard in:
| Gepubliceerd in: | Expert Opin Pharmacother |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293334/ https://ncbi.nlm.nih.gov/pubmed/25346016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2015.973850 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|